doxorubicin hydrochloride has been researched along with 2-(quinolin-2-ylmethylene)hydrazinecarbothioamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, K; Chen, Q; Chen, Z; Ding, J; Huang, H; Jiang, H; Ku, X; Li, M; Lin, L; Liu, H; Meng, L; Wang, X; Wang, Y; Zhu, C | 1 |
1 other study(ies) available for doxorubicin hydrochloride and 2-(quinolin-2-ylmethylene)hydrazinecarbothioamide
| Article | Year |
|---|---|
A series of alpha-heterocyclic carboxaldehyde thiosemicarbazones inhibit topoisomerase IIalpha catalytic activity.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Aldehydes; Animals; Antigens, Neoplasm; Antineoplastic Agents; Biocatalysis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Hydrolysis; Iron Chelating Agents; Mice; Models, Molecular; Neoplasm Transplantation; Protein Binding; Protein Structure, Tertiary; Structure-Activity Relationship; Thiosemicarbazones; Topoisomerase II Inhibitors | 2010 |